Evaluating Treatment Benefit Predictors using Observational Data: Contending with Identification and Confounding Bias
Yuan Xia, Mohsen Sadatsafavi, Paul Gustafson

TL;DR
This paper discusses methods to evaluate treatment benefit predictors using observational data, addressing challenges like confounding bias and identification issues to improve personalized treatment decisions.
Contribution
It introduces a framework for evaluating TBPs with observational data, including identification strategies and bias analysis, for binary treatment decisions in precision medicine.
Findings
Bias patterns are often unpredictable in observational evaluations.
Full confounding control is crucial to reduce bias in TBP assessment.
Identification of treatment benefit metrics can be achieved using observable data distributions.
Abstract
A treatment benefit predictor (TBP) is a function that maps patient characteristics to an estimate of the treatment benefit for that patient. Such predictors support optimizing individualized treatment decisions, which are central to precision medicine. However, evaluating the predictive performance of a TBP is challenging, as this often must be conducted in a sample where treatment assignment is not random. After briefly reviewing several metrics for evaluating TBPs, we show conceptually how to evaluate a pre-specified TBP using observational data from the target population, for a binary treatment decision at a single time point. We exemplify with a particular measure of discrimination (the concentration of benefit index) and a particular measure of calibration (the moderate calibration curve). The population-level definitions of these metrics involve the latent treatment benefit…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Policy and Management · Health Systems, Economic Evaluations, Quality of Life
